Correlation of platelet activating factor and age-related macular degeneration

被引:4
作者
Nitoda, Eirini [1 ]
Koutsilieris, Michael [2 ]
Brouzas, Dimitrios [1 ]
Koutsandrea, Chryssanthi [1 ]
Philippou, Anastasios [2 ]
Ladas, Dimitrios [1 ]
Moschos, Marilita M. [1 ]
机构
[1] Univ Athens, Dept Ophthalmol 1, Sch Med, Athens 11528, Greece
[2] Univ Athens, Dept Expt Physiol, Sch Med, Athens 11528, Greece
关键词
age-related macular degeneration; angiogenesis; para-inflammation; platelet activating factor; RECURRENT CHOROIDAL NEOVASCULARIZATION; PIGMENT EPITHELIAL-CELLS; FACTOR PAF; PHOTODYNAMIC THERAPY; INTRAVITREAL AFLIBERCEPT; OXIDATIVE STRESS; 5-YEAR INCIDENCE; GENE DELIVERY; TRAP-EYE; 2.0; MG;
D O I
10.1517/14728222.2014.930439
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To investigate the role of Platelet Activating Factor (PAF) in the pathogenesis and development of Age-Related Macular Degeneration (ARMD). Research design and methods: Fifty six patients with ARMD (24 patients with dry ARMD and 32 patients with wet ARMD) and 25 age-matched control participants underwent ophthalmological examination, including visual acuity measurement and evaluation of the retina. The participants were classified into three groups according to their retinal status, based on indirect fundoscopy, Optical Coherence Tomography and fluorescein angiography findings. In order to evaluate the concentrations of PAF in serum, blood samples were collected from all participants and were analyzed with ELISA technique. Results: The concentrations of PAF differed significantly according to macular lesions and were found to be lower in patients with ARMD than control participants. Conclusions: PAF levels are decreased along with the severity of ARMD. Understanding the role of PAF in pathogenesis of ARMD could be the impetus for the development of new therapies field of treatment of ARMD or even other retinal diseases.
引用
收藏
页码:987 / 997
页数:11
相关论文
共 102 条
[1]   One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration [J].
Abdel-Meguid, A ;
Lappas, A ;
Hartmann, K ;
Auer, F ;
Schrage, N ;
Thumann, G ;
Kirchhof, B .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2003, 87 (05) :615-621
[2]   Antiangiogenic Therapy for Ischemic Retinopathies [J].
Al-Latayfeh, Motasem ;
Silva, Paolo S. ;
Sun, Jennifer K. ;
Aiello, Lloyd Paul .
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (06)
[3]   A2E Induces IL-1β Production in Retinal Pigment Epithelial Cells via the NLRP3 Inflammasome [J].
Anderson, Owen A. ;
Finkelstein, Arthur ;
Shima, David T. .
PLOS ONE, 2013, 8 (06)
[4]  
[Anonymous], 1999, Arch Ophthalmol, V117, P1329
[5]   Platelet-activating factor acetylhydrolase [J].
Arai, H .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2002, 68-9 :83-94
[6]   RECURRENT CHOROIDAL NEOVASCULARIZATION AFTER MACULAR TRANSLOCATION SURGERY WITH 360-DEGREE PERIPHERAL RETINECTOMY [J].
Baer, Claxton A. ;
Rickman, Catherine Bowes ;
Srivastava, Sunil ;
Malek, Goldis ;
Stinnett, Sandra ;
Toth, Cynthia A. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (09) :1221-1227
[7]   Repair of the degenerate retina by photoreceptor transplantation [J].
Barber, Amanda C. ;
Hippert, Claire ;
Duran, Yanai ;
West, Emma L. ;
Bainbridge, James W. B. ;
Warre-Cornish, Katherine ;
Luhmann, Ulrich F. O. ;
Lakowski, Jorn ;
Sowden, Jane C. ;
Ali, Robin R. ;
Pearson, Rachael A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (01) :354-359
[8]   Retinal Microenvironment in Dry Age-Related Macular Degeneration: A Mini-Review [J].
Barnett, Brad R. ;
Handa, James T. .
GERONTOLOGY, 2013, 59 (04) :297-306
[9]   Lipid signaling in neural plasticity, brain repair, and neuroprotection [J].
Bazan, NG .
MOLECULAR NEUROBIOLOGY, 2005, 32 (01) :89-103
[10]  
Beauchamp MH, 2002, INVEST OPHTH VIS SCI, V43, P3327